Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Advanced Magnetics, Inc. (AMEX:AVM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
61 Mooney Street
Cambridge, MA 02138
Phone: (617) 497-2070
Fax: (617) 547-2445
Email: irdept@advancedmagnetics.com
Employees (last reported count): 24
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 46%
·Over the last 6 months:
 · one insider buy; 140.0K shares (4.8% of insider shares)
·Institutional: 26% (47% of float)
(16 institutions)
·Net Inst. Selling: 237.0K shares (+16.23%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Advanced Magnetics, Inc. develops, manufactures and markets organ-specific contrast agents to improve the diagnostic capabilities of soft tissue magnetic resonance imaging (MRI) scans. The Company's liver contrast agent, Feridex I.V., is approved and marketed in Europe, Japan, the United States, Argentina, South Korea, China and Israel. The Company's oral contrast agent, GastroMARK, used for delineating the bowel in MRI procedures, is approved and marketed in Europe and the United States. The Company has received an approvable letter, subject to certain conditions, from the United States Food and Drug Administration for Combidex, the Company's contrast agent for the diagnosis of lymph node disease. Code 7228, the Company's lead MRI contrast agent in the development pipeline, is currently in Phase II clinical studies. The product is being evaluated for MRI applications in both cardiology and oncology.
More from Market Guide: Expanded Business Description

Financial Summary
Advanced Magnetics, Inc. develops, manufactures and markets organ-specific contrast agents to improve the diagnostic capabilities of soft tissue magnetic resonance imaging (``MRI'') scans. For the nine months ended 6/30/01, revenues rose 64% to $4.4 million. Net income before acct. change totaled $719 thousand vs. a loss of $2.5 million. Results reflect license fee revenues from a license and marketing arrangement and the completion of certain clinical trials for Combidex.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Jerome Goldstein, 61
Chairman, CEO, Treasurer
$253K--  
Leonard Baum, 47
Pres, CEO
239K--  
James Matheson, 56
VP-Fin.
--  --  
Paula Jacobs, Ph.D., 56
VP-Devel.
138K$3.6K
Dennis Lawler, 46
VP-Quality Control
--  --  
Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:AVMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 10-Jan-2001
$2.25 
Recent Price$3.80 
52-Week High
on 20-July-2001
$5.05 
Beta0.42 
Daily Volume (3-month avg)9,682 
Daily Volume (10-day avg)10.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-18.9%
52-Week Change
relative to S&P500
+8.7%
Share-Related Items
Market Capitalization$25.2M
Shares Outstanding6.64M
Float3.60M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.38 
Earnings (ttm)-$0.00 
Earnings (mrq)$0.10 
Sales (ttm)$0.94 
Cash (mrq)$4.25 
Valuation Ratios
Price/Book (mrq)1.60 
Price/EarningsN/A 
Price/Sales (ttm)4.06 
Income Statements
Sales (ttm)$6.31M
EBITDA (ttm)$288.0K
Income available to common (ttm)-$38.0K
Profitability
Profit Margin (ttm)-0.6%
Operating Margin (ttm)-3.4%
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-0.12%
Return on Equity (ttm)-0.25%
Financial Strength
Current Ratio (mrq)6.42 
Debt/Equity (mrq)0 
Total Cash (mrq)$28.2M
Short Interest
As of 8-Aug-2001
Shares Short10.0K
Percent of Float0.3%
Shares Short
(Prior Month)
10.0K
Short Ratio0.67 
Daily Volume15.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.